Erosions, erosions, and erosions! Device closure of atrial septal defects: How safe is safe?

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 2, 2012, Pages 168-174

  Diab, Karim ^a,b   Kenny, Damien ^c   Hijazi, Ziyad M ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; AORTA EROSION; AORTA PERFORATION; AORTA ROOT; ASYMPTOMATIC DISEASE; BALLOON DILATATION; DEVICE SAFETY; DISEASE COURSE; EQUIPMENT DESIGN; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART DISEASE; HEART EROSION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION; SEPTAL OCCLUDER; SYMPTOM; TREATMENT FAILURE; TREATMENT INDICATION;

AORTIC RUPTURE; CARDIAC CATHETERIZATION; HEART ATRIA; HEART INJURIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PATIENT SAFETY; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864189332     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24517     Document Type: Review

References (23)

1. Dickinson DF, Arnold R, Wilkinson JL,. Congenital heart disease among 160,480 live-born children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J 1981; 46: 55-62. (Pubitemid 11018962)
2. Brickner ME, Hillis LD, Lange RA,. Congenital heart disease in adults. First of two parts. N Engl J Med 2000; 342: 256-263. (Pubitemid 30058959)
3. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K,; The Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39: 1836-1844. (Pubitemid 34595297)
4. Visconti KJ, Bichell DP, Jonas RA, Newburger JW, Bellinger DC,. Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children. Circulation 1999; 100 (19 Suppl): II145-II150. (Pubitemid 29523525)
5. United States Food and Drug Administration. Available at: Accessed June 4, 2012.
6. United States Food and Drug Administration. Available at: Accessed June 4, 2012.
7. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS,. Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496-502. (Pubitemid 39578516)
8. Hellenbrand W,. Update from the SJM Erosion Panel. Presented at the Pediatric and Adult Interventional Cardiac Symposium, April 15-18, 2012;Chicago, IL.
9. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr,. Analysis of the US food and drug administration manufacturer and user facility device experience database for adverse events involving amplatzer septal occluder devices and comparison with the society of thoracic surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 2009; 137: 1334-1341.
10. Delaney JW, Li JS, Rhodes JF,. Major complications associated with transcatheter atrial septal occluder implantation: A review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis 2007; 2: 256-264. (Pubitemid 47161798)
11. Crawford G, Brindis RG, Krucoff MW, Mansalis BP, Carroll JD,. Percutaneous atrial septal occluder devices and cardiac erosion: A review of the literature. Catheter Cardiovasc Interv 2012;DOI: 10.1002/ccd.24347.
12. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J,. Cardiac perforation after device closure of atrial septal defects with the amplatzer septal occluder. J Am Coll Cardiol 2005; 45: 1213-1218. (Pubitemid 40523139)
13. Misra M, Sadiq A, Namboodiri N, Karunakaran J,. The 'aortic rim' recount: Embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure. Interact Cardiovasc Thorac Surg 2007; 6: 384-386. (Pubitemid 46849712)
14. Brown S, Gewillig M,. Perforation of the aortic sinus after closure of atrial septal defects with the Atriasept occluder. Catheter Cardiovasc Interv 2009; 74: 298-301.
15. Murphy JC, Walsh SJ, Spence MS,. Late aortic perforation with an Atriasept device resulting in life-threatening tamponade. Catheter Cardiovasc Interv 2010; 76: 132-134.
16. Trepels T, Zeplin H, Sievert H, et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003; 58: 111-113. (Pubitemid 36055315)
17. Cecconi M, Quarti A, Bianchini F, et al. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg 2006; 81: e29-e30. (Pubitemid 43775603)
18. Amin Z, Hijazi ZM, Bass JL, et al. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv 2008; 72: 74-79. (Pubitemid 352008987)
19. Christen T, Mach F, Didier D, et al. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr 2005; 6: 465-469. (Pubitemid 41700717)
20. El-Said H, Moore JW,. Erosion by the amplatzer septal occluder: Experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 2009; 73: 925-930.
21. Available at: Accessed June 4, 2012.
22. Kitano M, et al. The influence of morphological changes in amplatzer device on the atrial and aortic walls following transcatheter closure of atrial septal defects. J Interv Cardiol 2009; 22: 83-91.
23. Carroll JD,. Device erosion. Catheter Cardiovasc Interv 2009; 73: 931-932.